Literature DB >> 15958653

Expression of metallothoinein isoform 3 is restricted at the post-transcriptional level in human bladder epithelial cells.

Scott H Garrett1, Seongmi Park, Mary Ann Sens, Seema Somji, Rajendra K Singh, Venugopal B R K Namburi, Donald A Sens.   

Abstract

This study was designed to define the effect that overexpression of MT-3 would have on a cell culture model of bladder urothelium. Stable and inducible transfection was used to achieve overexpression of the MT-3 gene in the UROtsa cell line. When the UROtsa cells were stably transfected with the MT-3 coding sequence, there was highly elevated expression of MT-3 mRNA, but no MT-3 protein. An inducible vector showed that low basal levels of MT-3 mRNA and protein could be produced, but that induction only increased MT-3 mRNA and not protein. The clones expressing low basal levels of MT-3 protein also had reduced growth rates compared to control cells. Site directed mutagenesis was used to produce an MT-3 coding sequence where the prolines in positions 7 and 9 were converted to threonines. When this altered MT-3 was stably transfected into the UROtsa cells, the cells were able to accumulate the mutated form of the MT-3 protein. These studies show that MT-3 protein expression is inhibited by post-transcriptional control in the urothelial cell. Modifying the MT-3 protein to resemble the MT-1 isoform removes this component of post-transcriptional control and allows accumulation of the mutated MT-3 protein. The altered sequence involved in post-transcriptional control of MT-3 protein expression is the same sequence implicated in the neuronal growth inhibitory activity associated specifically with the MT-3 isoform of the MT gene family.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15958653     DOI: 10.1093/toxsci/kfi231

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  4 in total

1.  Absence of Metallothionein 3 Expression in Breast Cancer is a Rare, But Favorable Marker of Outcome that is Under Epigenetic Control.

Authors:  Seema Somji; Scott H Garrett; Xu Dong Zhou; Yun Zheng; Donald A Sens; Mary Ann Sens
Journal:  Toxicol Environ Chem       Date:  2010-10       Impact factor: 1.437

Review 2.  Cadmium as a possible cause of bladder cancer: a review of accumulated evidence.

Authors:  Molka Feki-Tounsi; Amel Hamza-Chaffai
Journal:  Environ Sci Pollut Res Int       Date:  2014-06-04       Impact factor: 4.223

3.  Role of metallothioneins in benign and malignant thyroid lesions.

Authors:  Bartosz Pula; Pawel Domoslawski; Marzena Podhorska-Okolow; Piotr Dziegiel
Journal:  Thyroid Res       Date:  2012-12-28

4.  The effect of Benzothiazolone-2 on the expression of Metallothionein-3 in modulating Alzheimer's disease.

Authors:  Sudeep Roy; Jaromir Gumulec; Akhil Kumar; Martina Raudenska; Mohd Hassan Baig; Hana Polanska; Jan Balvan; Mansi Gupta; Petr Babula; Jan Odstrčilík; Inho Choi; Ivo Provaznik; Michal Masarik
Journal:  Brain Behav       Date:  2017-08-15       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.